Company Overview
Great Eccleston Medical Supplies Limited is listed at the official companies registry as Active Private Limited Company. The company was incorporated on Tuesday 11 March 1997, so this is a well established company. Great Eccleston Medical Supplies Limited has been in business for 29 years. The accounts status is total exemption full and the accounts are next due on Thursday 30 April 2026.
Registered Address

59 Higher Parr Street, St. Helens, WA9 1AD
Credit Reports Available

These credit rating reports are available now:


Credit Analysts Report
Get Report >>

Standard Credit Report
Get Report >>

Basic Credit Report
Get Report >>

24/7 credit rating data feed - no UK company credit reports are updated faster

Companies House Data
Company NameGREAT ECCLESTON MEDICAL SUPPLIES LIMITED
Company Number03331442
Registered Office Address59 Higher Parr Street
 WA9 1AD
Company CategoryPrivate Limited Company
Company StatusActive
Country of OriginUnited Kingdom
Incorporation Date11/03/1997
Accounting Reference Date Day31
Accounting Reference Date Month7
Accounts Next Due Date30/04/2026
Accounts Last Made Up Date31/07/2024
Accounts Account CategoryTOTAL EXEMPTION FULL
Returns Next Due Date08/04/2017
Returns Last Made Up Date11/03/2016
Directors & Members
Show Resigned
Philip Ashton - Director
(British, 46 years old, born November 1980)
Appointed 02 August 2021
 Active
David Ashton - Director
(British, 43 years old, born October 1983)
Appointed 02 August 2021
 Active
Imraan Khan - Director
(British, 45 years old, born August 1981)
Appointed 02 August 2021
 Active
Secretaries
Show Resigned
Other Company Directorships
Philip Ashton
APEX PHARMA LTD
DAVINA PHARMACY LIMITED
DERBYSHIRE PHARMACEUTICALS LTD
FARLEYS CHEMIST LTD
PHOCUS LIMITED
UNITED PHARMACEUTICALS LTD
David Ashton
APEX PHARMA LTD
DAVINA PHARMACY LIMITED
DERBYSHIRE PHARMACEUTICALS LTD
FARLEYS CHEMIST LTD
UNITED PHARMACEUTICALS LTD
Imraan Khan
ALLIANCE MRK PROPERTIES LTD
APEX PHARMA LTD
BOLTON HOMECARE SUPPORT LTD
CLOUD HEALTHCARE LTD
DAVINA PHARMACY LIMITED
DERBYSHIRE PHARMACEUTICALS LTD
FARLEYS CHEMIST LTD
OAKFIELD ENTERPRISES LIMITED
OLDBRIDGE HEALTHCARE LIMITED
PHARMACEUTICAL MANAGEMENT SERVICES LIMITED
UNITED PHARMACEUTICALS LTD
WELLBROOK VENTURES LIMITED
Balance Sheet Unlock full report
Accounts Date 31-Jul-2024 31-Jul-2022 31-Jul-2021
Balance Sheet
Fixed Assets 1,161 1,161 1,461
Current Assets 839,226 839,226 679,699
Creditors Due Within One Year 284,090 284,090 242,525
Working Cap 555,136 555,136 437,174
Total Assets Less Current Liabilities 556,297 556,297 438,635
Long-term Liabilities - - 277
Net Assets - - 438,358
Share Capital & Reserves
Share Cap - - -
Profit & Loss Reserves - - -
Other Reserves - - -
Shareholders Funds - - 438,358
Common Size Financial Analysis Unlock full report
Accounts Date 31-Jul-2024 31-Jul-2022 31-Jul-2021
Tangible Fixed Assets - - -
Fixed Assets 0.1% 0.1% 0.2%
Stocks Inventory - - -
Debtors 65.1% 65.1% 52.5%
Cash Bank In Hand 30.8% 30.8% 37.9%
Current Assets 99.9% 99.9% 99.8%
Creditors Due Within One Year 33.8% 33.8% 35.6%
Net Current Assets Liabilities 66.1% 66.1% 64.2%
Creditors Due After One Year - - -
Accruals Deferred Income - - -
Provisions For Liabilities Charges - - -
Net Assets Liabilities Including Pension Asset Liability - - -
Called Up Share Capital - - -
Share Capital Allotted Called Up Paid - - -
Profit Loss Account Reserve - - -
Shareholder Funds - - 64.4%
Capital Employed - - -
Total Assets Less Current Liabilities 66.2% 66.2% 64.4%
Financial Ratio Analysis Unlock full report
Accounts Date 31-Jul-2024 31-Jul-2022 31-Jul-2021
Liquidity Ratio 3.0 3.0 2.8
Solvency Ratio - - 2.8
Reserves to Assets - - -
Secured Creditors Unlock full report
Mortgages Charges 2
Mortgages Outstanding 2
Mortgages Part Satisfied 0
Mortgages Satisfied 0
Assets and Debt Analysis Unlock full report
Accounts Date 31-Jul-2024 31-Jul-2022 31-Jul-2021
Assets 840,387 840,387 681,160
Debt - - 242,802
Net Assets/Debt - - 438,358

The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.

The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency.

Unlock full report  The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency.   The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency.

This review of public record balance sheet and company status information is presented under the terms of Open Government Licence and is for informational purposes only, is general in nature, and is not intended as an opinion or advice for any specific circumstances. The commentary and the colour band score is not a credit rating or credit risk assessment.

This review does not constitute a full credit rating or credit risk assessment based on the full analysis and credit score algorithms used in our credit reports. A full credit report may also provide information relating to trade payment history and county court or court judgments if any.

Public Record Information Unlock full report
Exact Court Judgements
Period of Months Last 12m 13-24m 25-36m 37-48m 49-60m 61-72m
Number of Exact CCJS X Y Y X X Y
Value of Exact CCJS YXY YK S S X KX
Supplier Credit Limits Unlock full report
Date Sector Notified Amount Terms
XK-SXY XKXYXK SXSKXYXK £X,000 XS XYSKS
SK-SYY SKXYXKYKKY KSXX KKXXYXS £YY,000 YS XYSKS SK YXXSXS
YK-SXY XKXYXYYK SXSXYXK £SX,000 XS XYSKS
Payment Records Unlock full report
Payment Records from it's suppliers' company ledger show how a company is paying its suppliers

Payment Analysis

Total Invoices Paid Before
30 days due		 Paid After
30 days due		 Owing Before
30 days due		 Owing after
30 days due
XYX SX K YX X
Company Valuation Analysis Unlock full report

Going Concern Valuation

The going concern valuations value the company on the basis that it continues to trade without the threat of liquidation for the foreseeable future. These valuations are primarily profit and cashflow based.

Valuations Valuation Measures
Estimated High Value £XSI,000 Retained Profit £YX,000
Estimated Mid Value £YY,000 EBIT £SY,000
Estimated Low Value £X,000 EBITDA £SSX,000

Liquidation Valuation

The liquidaton valuation values the company as if it were to cease trading and assets were subject to rapid disposal to cover liabilities. This valuation is primarily asset based.

Valuations Valuation Measures
Estimated High Value £XY,000 Total Assets £XIX,000
Estimated Mid Value £Y,000 Net Assets £YX,000
Estimated Low Value £S,000 Tangible Equity £SX,000

The above valuations are based on our own algorithms and take no account of many factors that can influence actual valuations realized and should not therefore be assumed to be accurate.
Credit Status Checklist Unlock full report
Business Growth Please purchase a report to see true comments
EBITDA Purchase a report to see true comments
Dividends Please purchase a report to see true comments about this company
Retained Profits Retained Profits for this company
Debt Interest Debt Interest for this company
Cash Flow Cash Flow for this company
CCJs CCJs for this company
Age of Company Age of Company for this company
Solvency Solvency for this company
Secured Creditors Secured Creditors for this company
Ownership Ownership for this company


First Report Score: (0-10) X
Financial Status Guide:
10 Very Strong
9 Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical

Risk Score Trend

Risk Rating Unlock full report

This is the credit risk assessment used by one of the top UK credit reference agencies.

Risk Score (1-100) X
Risk Band Description XXMXMXMX SISX
Risk Assessment Meeting of Creditors
Credit Rating XSKX
Altman Z Score Credit Risk Rating Unlock full report

There have been many bankruptcy predictors developed, however none has been so thoroughly tested and broadly accepted as the Altman Z-Score.

Z Score X
Risk Band XY
Risk Band Description The Z Score is not used for small companies where full accounts are not filed because profit and loss account items are required to calculate the score.

Z Score Bands

1 Low Risk 3.00 and above
2 Caution 2.63 - 2.99
3 Risk of Failure within 2 years 1.24 - 2.62
4 High Probability Failure Below 1.24
Other Business around WA9 1AD
No other companies found in the same location
Document Filings
Confirmation statement made on 23 August 2025 with no updates
Confirmation statement made on 23 August 2024 with no updates
Confirmation statement made on 23 August 2023 with no updates
Notification of Apex Pharma Ltd as a person with significant control on 23 August 2023
Cessation of Imraan Khan as a person with significant control on 22 June 2023
Confirmation statement made on 23 August 2022 with no updates
Previous accounting period shortened from 30 November 2021 to 31 July 2021
Confirmation statement made on 23 August 2021 with updates
Confirmation statement made on 21 August 2021 with updates
Cessation of Rachel Helen Molloy as a person with significant control on 2 August 2021
Cessation of Paul Matcalf as a person with significant control on 2 August 2021
Appointment of Mr Imraan Khan as a director on 2 August 2021
Appointment of Mr David Ashton as a director on 2 August 2021
Appointment of Mr Philip Ashton as a director on 2 August 2021
Termination of appointment of Thomas Lennard Cutting as a director on 2 August 2021
Notification of Imraan Khan as a person with significant control on 2 August 2021
Cessation of Christian Jane Hynes as a person with significant control on 2 August 2021
Cessation of Thomas Lennard Cutting as a person with significant control on 2 August 2021
Cessation of Stephen Nicholas Cottam as a person with significant control on 2 August 2021
Terms and Conditions Cancellations Contact Us

In using this service you agree to the Terms and Conditions

© 2026 Check Free